Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene

被引:82
作者
Asklund, T
Appelskog, IB
Ammerpohl, O
Langmoen, IA
Dilber, MS
Aints, A
Ekström, TJ
Almqvist, PM
机构
[1] Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden
关键词
malignant glioma; gene therapy; HSVtk; ganciclovir; gap junction; connexin; 43; bystander effect;
D O I
10.1016/S0014-4827(02)00052-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ability of herpes simplex virus type I thymidine kinase (HSV-tk)-expressing cells incubated with ganciclovir (GCV) to induce cytotoxicity in neighboring HSV-tk-negative (bystander) cells has been well documented. Although it has been suggested that this bystander cell killing occurs via the transfer of phosphorylated GCV, the mechanism(s) of this bystander effect and the importance of gap junctions for the effect of prodrug/suicide gene therapy in primary human glioblastoma cells remains elusive. Surgical biopsies of malignant gliomas were used to establish explant primary cultures. Proliferating tumor cells were characterized immunohistochemically and found to express glial tumor markers including nestin, vimentin, glial fibrillary acidic protein (GFAP), S-100, and gap junction protein connexin 43 (Cx43). Western blot analysis revealed the presence of phosphorylated isoforms of Cx43 and Calcein/DiI fluorescent dye transfer showed evidence of efficient gap junction communication (GJC). In order to study the effect(s) of prodrug/suicide gene therapy in these cultures, human glioblastoma cell cultures were transfected with the HSVtk gene for transient or stable expression. Ganciclovir treatment of these cultures led to >90% of cells dead within I week. Eradication of cells could be inhibited by the addition of alpha-glycyrrhetinic acid (AGA), a GJC inhibitor. In parallel experiments, AGA decreased the immunodetection of phosphorylated Cx43 as analyzed by Western blot and inhibited fluorescent dye transfer. In conclusion, these observations are consistent with GJC as the mediator of the bystander effect in primary cultures of human glioblastoma cells by the transfer of phosphorylated GCV from HSVtk gene transfected cells to untransfected ones. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 44 条
  • [1] DEVELOPMENT OF ANTITUMOR IMMUNITY FOLLOWING THYMIDINE KINASE-MEDIATED KILLING OF EXPERIMENTAL BRAIN-TUMORS
    BARBA, D
    HARDIN, J
    SADELAIN, M
    GAGE, FH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4348 - 4352
  • [2] Beyer E C, 1993, Int Rev Cytol, V137C, P1
  • [3] IN-VITRO EVIDENCE THAT METABOLIC COOPERATION IS RESPONSIBLE FOR THE BYSTANDER EFFECT OBSERVED WITH HSV TK RETROVIRAL GENE-THERAPY
    BI, WL
    PARYSEK, LM
    WARNICK, R
    STAMBROOK, PJ
    [J]. HUMAN GENE THERAPY, 1993, 4 (06) : 725 - 731
  • [4] REGRESSION OF ESTABLISHED MACROSCOPIC LIVER METASTASES AFTER IN-SITU TRANSDUCTION OF A SUICIDE GENE
    CARUSO, M
    PANIS, Y
    GAGANDEEP, S
    HOUSSIN, D
    SALZMANN, JL
    KLATZMANN, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 7024 - 7028
  • [5] In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy
    Cirenei, N
    Colombo, BM
    Mesnil, M
    Benedetti, S
    Yamasaki, H
    Finocchiaro, G
    [J]. GENE THERAPY, 1998, 5 (09) : 1221 - 1226
  • [6] DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104
  • [7] Suicide genes and bystander killing: Local and distant effects
    Dilber, MS
    Smith, CIE
    [J]. GENE THERAPY, 1997, 4 (04) : 273 - 274
  • [8] Dilber MS, 1997, CANCER RES, V57, P1523
  • [9] Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase ganciclovir gene therapy
    Duflot-Dancer, A
    Piccoli, C
    Rolland, A
    Yamasaki, H
    Mesnil, M
    [J]. GENE THERAPY, 1998, 5 (10) : 1372 - 1378
  • [10] Elshami AA, 1996, GENE THER, V3, P85